Medical News

RSS

14 million sleep records expose the social divide in sleep

More favorable social conditions are associated with steadier, longer sleep, according to long-term Fitbit data from the All of Us Research Program.

13 Nov 2026

Personalized mobile health coaching reduces gestational diabetes among pregnant women

A continuous, personalized mobile health (mHealth) coaching programme can significantly reduce gestational diabetes incidence among high-risk pregnant women, independent of changes to maternal weight - according to an international study published today in the Lancet Digital Health.

13 Nov 2026

Machine learning predicts mortality risk after a severe heart attack

Machine learning models were able to predict mortality in hospital and in the six months after a type of heart attack, according to results presented today at ESC Digital & AI Summit 2026.

13 Nov 2026

A simpler way to rank heart transplant patients could save lives

A validated mortality score outperformed the current six-status system, potentially reshaping US donor heart allocation and prioritizing sicker patients.

13 Nov 2026

Aging reduces the brain's waste-flushing process during sleep

As people age, they may sleep for shorter periods and wake up more frequently during the night. In addition to those disruptions, MIT researchers have now discovered that a process responsible for flushing waste from the brain during sleep is commonly impaired in older people.

13 Nov 2026

Your plant-based dairy swaps could leave you short on iodine

A UK dietary model links dairy reduction to greater iodine inadequacy, highlighting iodized bread and fortified plant-based alternatives as policy options.

13 Nov 2026

Your brain may reveal your Alzheimer’s risk before symptoms appear

Researchers developed the ARC brain connectivity score to distinguish cognitive resilience from vulnerability and improve early Alzheimer’s risk assessment.

13 Nov 2026

Broad genomic sequencing extends survival in advanced lung cancer patients

New research in the November 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)-testing a large panel of dozens or hundreds of genes at once-before starting treatment, compared with patients who received more limited biomarker testing of just one or two genes.

13 Nov 2026

DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancer

Molecular diagnostic approaches are expanding what information is available for clinicians and laboratory professionals, including uncovering antimicrobial resistance, identifying pathogens missed by conventional methods, revealing cancer recurrence risks and characterizing complex tumor biology.

13 Nov 2026

Single-cell spatial atlas profiles 850,000 cells across breast cancer progression

Researchers at The University of Texas MD Anderson Cancer Center have created one of the most detailed maps to date of the cell environment surrounding ductal carcinoma in situ (DCIS), the most common form of preinvasive, or stage 0, breast cancer.

13 Nov 2026

Multicenter trial validates continuous pregnancy-to-postpartum mobile health coaching program

A continuous, personalized mobile health (mHealth) coaching program can significantly reduce gestational diabetes incidence among high-risk pregnant women, independent of changes to maternal weight – according to an international study published today in the Lancet Digital Health.

13 Nov 2026

University of Utah researchers target cardiac fibroblast protein AEBP1

Most heart failure cases are caused to a large degree by a build-up of excess scar tissue in the heart, which currently has no treatments.

13 Nov 2026

Sino Biological advances AI-designed molecule validation with 4RISE™

AI can generate protein candidates at an unprecedented speed, but experimental validation remains essential to determine whether they properly express, bind targets, and demonstrate the desired biological properties.

From Sino Biological Inc. 13 Nov 2026

PlaqueTec’s BIOPATTERN trial passes 100 patients and expands to 8 NHS centers

PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to reveal the biological drivers of atherosclerotic cardiovascular disease (ASCVD), today announced that its BIOPATTERN clinical trial has recruited its 100th patient and expanded to eight NHS specialist cardiac centers.

From PlaqueTec 12 Nov 2026

New surgical approaches aim to improve stomach cancer outcomes

Sometimes innovation in cancer care means developing something entirely new. Other times, it means returning to an old idea with the knowledge and tools to make it work better.

12 Nov 2026

Study highlights healthcare barriers facing volunteer firefighters in Texas

In recent years, several organizations have recognized the firefighting profession's unique and substantial work-related health hazards, including cancers, heart disease, chronic respiratory illnesses and post-traumatic stress disorder (PTSD).

12 Nov 2026

US sexual harassment reports increase sharply between 2018 and 2024

The #MeToo movement gained global momentum in 2017, drawing attention to sexual harassment (SH) and its harms. More than 80 anti-sexual harassment bills subsequently passed across 25 US states, largely focusing on workplace harassment.

12 Nov 2026

Scientists unveil first comprehensive atlas of basal ganglia cell types

Capturing a complete picture of what causes brain diseases from schizophrenia and Parkinson's disease to addiction has long remained a challenge to scientists.

12 Nov 2026

ACC launches initiative to strengthen cardiovascular disease prevention

A new initiative from the American College of Cardiology (ACC) aims to reduce atherosclerotic cardiovascular disease (ASCVD) events on a population scale by addressing persistent gaps in knowledge about cardiovascular disease prevention and implementation in clinical practice.

12 Nov 2026

Placental stem cell therapy shows promise for diabetic foot ulcers

An experimental cell therapy was well tolerated in 10 people with chronic diabetic foot ulcers, according to first-in-human study led by researchers at Wake Forest Institute for Regenerative Medicine (WFIRM).

12 Nov 2026